Morphosys
Aktiengesellschaft
MorphoSys AG is a German biopharmaceutical company founded in 1992. The company is headquartered near Munich, Germany, and has a wholly owned subsidiary, MorphoSys US Inc., in Boston, Massachusetts, in the US. The company has various antibody, protein and peptide technologies that it uses to discover and develop both proprietary and partnered drug candidates. The company has more than 100 drugs in its wider pipeline that are being investigated as treatments for a variety of diseases. While many of these are being developed in partnership with pharma and biotech companies, MorphoSys also has a proprietary pipeline with a focus on cancer and autoimmune diseases.
Source: Wikipedia · CC BY-SA 4.0
last observed
Activity Score
0
confidence 55 % · metrics-v1
Hiring Momentum 30d
—
not enough monitored evidence
Product Velocity
0
confidence 70 % · metrics-v1
AI Adoption
0
confidence 60 % · metrics-v1
Corporate Change Index
0
confidence 82 % · cci-v1
11 active sensors·2 observations·0 historical changes·0 structured events·historical coverage 100 %·observed since 2026-09-13
Compare Morphosys with peers on activity, hiring, product velocity, AI adoption, locations and events.
Compare companies